Coverage of cervical cancer prevention interventions among people in Australia who inject drugs
Cervical screening coverage among this sample of people who inject drugs was similar to the Australian population. Health promotion messaging that focuses on the availability of self-sampling and the importance of regular screening may improve coverage among those overdue for screening. HPV vaccination was lower than the general population, warranting targeted efforts to offer the vaccine to eligible people who inject drugs.
Authors
- Rachel Sutherland (ORCID: https://orcid.org/0000-0001-5337-1751)
- Samantha Colledge‐Frisby (ORCID: https://orcid.org/0000-0003-3571-0136)
- Dorothy A. Machalek (ORCID: https://orcid.org/0000-0002-4101-8085)
- Amy Peacock (ORCID: https://orcid.org/0000-0002-5705-2026)
- Phillip J. Read (ORCID: https://orcid.org/0000-0001-5422-3777)
- Olivia Price (ORCID: https://orcid.org/0000-0002-2259-735X)
- Daisy Gibbs (ORCID: https://orcid.org/0000-0002-2116-8190)
Institutions
- University of Tasmania (AU)
- Royal Women's Hospital (AU)
- Alcohol and Drug Foundation (AU)
- UNSW Sydney (AU)
- South Eastern Sydney Local Health District (AU)
Publication Details
- Journal
- International Journal of Drug Policy
- Published
- 2024-08-22
- DOI
- https://doi.org/10.1016/j.drugpo.2024.104566
- Citations
- 1
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Department of Health and Aged Care, Australian Government